If you believe (as I do) that Otrexup will be approved by the FDA then it is a perfect time to buy.
All of the points covered in the recent Jefferies conference were overwhelmingly pointing to a much higher share price - I think beginning with the first bit of news - that could come at any time - and continue up as the company executes on their business plan. Listen to the replay of the conference web-cast (from the Jefferies analyst's introduction and Dr. Wotton's presentation) and make up your own mind.